Mika Mustonen

ORCID: 0000-0002-7899-0564 · 1 paper in corpus

rct 2004

Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen

Climacteric : the journal of the International Menopause Society ·doi:10.1080/13697130310001651445

OBJECTIVE: Two randomized comparative multicenter studies were conducted to establish the endometrial safety and tolerability of a triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate (E2V/MPA) therapy reg…